martes, 6 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· July 29, 2026

KLA Corp (KLAC) Q4 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ...

View original at finance.yahoo.com
KLA Corp (KLAC) Q4 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... This article first appeared on GuruFocus. Revenue: $3.66 billion, a record high, up 7% sequentially and 15% year-over-year…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Advanced packaging process control systems revenue is expected to grow to approximately $1.1 billion in 2026, up more than 70% year-over-year.

    60% confidence
  • Revenue reached a record $3.66 billion, up 7% sequentially and 15% year-over-year, surpassing the midpoint of guidance.

    60% confidence
  • KLA Services revenue was $820 million, up 17% year-over-year, reflecting strong customer reliance on KLA's tools.

    60% confidence
  • The competitive landscape in China poses challenges, with local suppliers potentially gaining share if import restrictions are lifted.

    60% confidence
  • The company is dealing with supply chain constraints, particularly in long lead-time materials, affecting first-half performance.

    60% confidence
  • September quarter revenue guidance is $4 billion, plus or minus $200 million, with gross margin guidance of 62.5% plus or minus 1 percentage point.

    60% confidence
  • KLA is facing challenges from a difficult memory pricing environment and tariff headwinds impacting gross margins.

    60% confidence
  • KLA's ability to raise prices to offset increased costs, particularly in memory, is limited despite strong demand.

    60% confidence
  • The company is experiencing strong demand driven by AI infrastructure investments and advanced packaging requirements.

    60% confidence
  • Gross margin guidance remains flat despite a 10% revenue increase, indicating ongoing cost pressures.

    60% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com